Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles

Journal of Gastroenterology
Tomohiro Terada, Daiki Hira

Abstract

The efficacy and safety of pharmacotherapies are determined by the complex processes involved in the interactions between drugs with the human body, including pharmacokinetic aspects. Among pharmacokinetic factors, it has been recognized that drug transporters play critical roles for absorption, distribution and excretion of drugs, regulating the membrane transport of drugs. The vast amounts of information on drug transporters collected in the past 20 years have been organized according to biochemical, molecular, genetic, and clinical analyses. Novel technologies, public databases, and regulatory guidelines have advanced the use of such information in drug development and clinical practice. In this review, we selected some clinically important drug transporters expressed in the intestine and liver, and introduced the research history and current knowledge of their pharmacokinetic, pathophysiological, and pharmacogenetic implications.

References

Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A T FojoI Pastan
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I B RoninsonI Pastan
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·E JacqueminP J Meier
May 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J KartenbeckD Keppler
May 23, 1998·The Journal of Biological Chemistry·T GerloffP J Meier
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Jan 6, 1999·Seminars in Liver Disease·H Suzuki, Y Sugiyama
May 18, 1999·The Journal of Biological Chemistry·T HirohashiY Sugiyama
Jan 25, 2000·The Journal of Biological Chemistry·T HirohashiY Sugiyama
May 29, 2000·Journal of Pharmaceutical Sciences·M SugawaraM E Ganapathy
Jun 30, 2000·Biochemical and Biophysical Research Communications·I TamaiA Tsuji
Aug 2, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M G Donner, D Keppler
Feb 19, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·George L SchefferRik J Scheper
Nov 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Johan W JonkerAlfred H Schinkel
Jan 1, 2003·Biochimica Et Biophysica Acta·B Hagenbuch, P J Meier
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria RiusDietrich Keppler
Nov 19, 2003·Pflügers Archiv : European journal of physiology·Matthias A HedigerElspeth A Bruford
Feb 18, 2004·Current Drug Metabolism·Tomohiro Terada, Ken-ichi Inui
Jul 27, 2005·British Journal of Clinical Pharmacology·Balram ChowbayEdmund J D Lee
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Lauri I KajosaariJanne T Backman
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·P Krishnamurthy, J D Schuetz
Jun 21, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wei ZhangHong-Hao Zhou
Jul 19, 2006·Pflügers Archiv : European journal of physiology·Anne T Nies, Dietrich Keppler
Nov 17, 2006·Pharmacogenetics and Genomics·Marja K PasanenMikko Niemi
Dec 6, 2006·Molecular and Cellular Biology·Antonius E van HerwaardenAlfred H Schinkel
Dec 7, 2006·Journal of the National Cancer Institute·George CusatisSharyn D Baker
Jan 9, 2007·Inflammatory Bowel Diseases·Johan Van LimbergenJack Satsangi
Apr 4, 2007·The Pharmacogenomics Journal·U GradhandM F Fromm
Mar 29, 2008·Expert Opinion on Drug Metabolism & Toxicology·Orsolya PolgarSusan E Bates
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Oct 30, 2008·Pharmaceutical Research·Tomoka FurukawaToshihisa Ishikawa
Jan 13, 2009·Advanced Drug Delivery Reviews·Robert W RobeySusan E Bates
May 29, 2009·Clinical Pharmacology and Therapeutics·J E KeskitaloM Niemi
Jun 3, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kacper A WojtalStephan R Vavricka
Jun 16, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fabienne ThomasJean Pierre Delord

❮ Previous
Next ❯

Citations

Jul 7, 2018·Therapeutic Drug Monitoring·Sarah AllegraAntonio DʼAvolio
Apr 26, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yanan TanYang Lu
Dec 19, 2019·Nature Reviews. Drug Discovery·Daniel J Drucker
Sep 15, 2020·Obstetrics and Gynecology·Intira SriprasertWendy J Mack
Apr 3, 2020·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·K DarneyL S Lautz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
E Spina, A P Caputi
Dialogues in Clinical Neuroscience
Nadia S Hejazi
Clinical Pharmacology and Therapeutics
U Amstutz, B C Carleton
© 2021 Meta ULC. All rights reserved